CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM NEW
Total 13F shares
2,098,383
Share change
+208,976
Total reported value
$8,191,000
Price per share
$3.92
Number of holders
23
Value change
+$838,584
Number of buys
10
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q4 2014

As of 31 Dec 2014, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,098,383 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Stanley-Laman Group, Ltd., Longwood Capital Partners LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, SOPHROSYNE CAPITAL LLC, THOMPSON DAVIS & CO., INC., Moors & Cabot, Inc., GRT CAPITAL PARTNERS LLC, and DAFNA Capital Management LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.